Defective Replication Stress Response Is Inherently Linked to the Cancer Stem Cell Phenotype.

[1]  Jinchuan Xing,et al.  Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer. , 2017, Cell Reports.

[2]  R. Weinberg,et al.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.

[3]  Yiling Lu,et al.  Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm , 2017, npj Systems Biology and Applications.

[4]  Yu Xia,et al.  Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells. , 2017, Cell stem cell.

[5]  Yiling Lu,et al.  Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays. , 2017, Cancer cell.

[6]  M. Salto‐Tellez,et al.  Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer , 2016, Journal of the National Cancer Institute.

[7]  U. Stenius,et al.  MEK-ERK-mediated phosphorylation of Mdm2 at Ser-166 in hepatocytes. Mdm2 IS ACTIVATED IN RESPONSE TO INHIBITED Akt SIGNALING. , 2016, The Journal of Biological Chemistry.

[8]  L. V. van't Veer,et al.  70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. , 2016, The New England journal of medicine.

[9]  P. Ernfors,et al.  New origin firing is inhibited by APC/CCdh1 activation in S-phase after severe replication stress , 2016, Nucleic acids research.

[10]  Raquel Herrador,et al.  A short G1 phase imposes constitutive replication stress and fork remodelling in mouse embryonic stem cells , 2016, Nature Communications.

[11]  A. Vindigni,et al.  Replication stress: getting back on track , 2016, Nature Structural &Molecular Biology.

[12]  L. Vermeulen,et al.  ER-Stress-Induced Differentiation Sensitizes Colon Cancer Stem Cells to Chemotherapy. , 2015, Cell reports.

[13]  Michael D. Brooks,et al.  Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer. , 2015, Cell stem cell.

[14]  E. Mardis,et al.  Development and verification of the PAM50-based Prosigna breast cancer gene signature assay , 2015, BMC Medical Genomics.

[15]  May Yin Lee,et al.  Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity , 2015, Nature.

[16]  A. Aguilera,et al.  Replication stress and cancer , 2015, Nature Reviews Cancer.

[17]  Roman Mezencev,et al.  SNAIL‐induced epithelial‐to‐mesenchymal transition produces concerted biophysical changes from altered cytoskeletal gene expression , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  A. Schambach,et al.  A Differentiation Checkpoint Limits Hematopoietic Stem Cell Self-Renewal in Response to DNA Damage , 2014 .

[19]  M. L. Beau,et al.  Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells , 2014, Nature.

[20]  G. Mills,et al.  Genome-wide Transcriptome Profiling of Homologous Recombination DNA Repair , 2014, Nature Communications.

[21]  M. Christmann,et al.  Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation , 2013, Nucleic acids research.

[22]  L. Ellis,et al.  Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1. , 2013, Cancer cell.

[23]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[24]  A. Gandarillas.  The mysterious human epidermal cell cycle, or an oncogene-induced differentiation checkpoint , 2012, Cell cycle.

[25]  F. Hamdy,et al.  Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1. , 2012, Cancer research.

[26]  D. Cortez,et al.  Monitoring the spatiotemporal dynamics of proteins at replication forks and in assembled chromatin using isolation of proteins on nascent DNA , 2012, Nature Protocols.

[27]  K. Horwitz,et al.  An Immunohistochemical Method to Study Breast Cancer Cell Subpopulations and Their Growth Regulation by Hormones in Three-Dimensional Cultures , 2011, Front. Endocrin..

[28]  Q. Shi,et al.  Proapoptotic Bid mediates the Atr-directed DNA damage response to replicative stress , 2011, Cell Death and Differentiation.

[29]  P. Plevani,et al.  Sensing of Replication Stress and Mec1 Activation Act through Two Independent Pathways Involving the 9-1-1 Complex and DNA Polymerase ε , 2011, PLoS genetics.

[30]  Justin C. Grindley,et al.  Tumour-initiating cells: challenges and opportunities for anticancer drug discovery , 2009, Nature Reviews Drug Discovery.

[31]  Jeffrey M. Rosen,et al.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.

[32]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[33]  T. Taguchi,et al.  Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers , 2009, Clinical Cancer Research.

[34]  F. Bertucci,et al.  Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. , 2009, Cancer research.

[35]  Hans Clevers,et al.  Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.

[36]  R. Zhao,et al.  TopBP1 activates ATR through ATRIP and a PIKK regulatory domain. , 2008, Genes & development.

[37]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[38]  Susan G Hilsenbeck,et al.  Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.

[39]  Jiri Bartek,et al.  An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.

[40]  S. Gygi,et al.  Profiling of UV-induced ATM/ATR signaling pathways , 2007, Proceedings of the National Academy of Sciences.

[41]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[42]  B. A. Ballif,et al.  ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage , 2007, Science.

[43]  U. Stenius,et al.  MEK-ERK-mediated Phosphorylation of Mdm2 at Ser-166 in Hepatocytes , 2007, Journal of Biological Chemistry.

[44]  Aaron Bensimon,et al.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication , 2006, Nature.

[45]  Dimitris Kletsas,et al.  Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.

[46]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  I. Poola,et al.  Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis , 2005, Nature Medicine.

[48]  Thomas Helleday,et al.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase , 2005, Nature.

[49]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[50]  A. Monteiro,et al.  Breast cancer susceptibility and the DNA damage response. , 2005, Cancer control : journal of the Moffitt Cancer Center.

[51]  S. Lowe,et al.  Intrinsic tumour suppression , 2004, Nature.

[52]  M. Hung,et al.  Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition , 2004, Nature Cell Biology.

[53]  Xinbin Chen,et al.  MDM2 Is a Negative Regulator of p21WAF1/CIP1, Independent of p53* , 2004, Journal of Biological Chemistry.

[54]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[55]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[56]  S. Elledge,et al.  Checking on the fork: the DNA-replication stress-response pathway. , 2002, Trends in cell biology.

[57]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.